Pfizer All other Specialty Care — Revenues: increased by 21.6% to $579.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.1%, from $486.00M to $579.00M. Over 2 years (FY 2023 to FY 2025), All other Specialty Care — Revenues: shows an upward trend with a 14.1% CAGR.
pfe_segment_all_other_specialty_care_revenues| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $702.00M | $696.00M | $643.00M | $586.00M | $575.00M | $188.00M | $185.00M | $202.00M | $775.00M | $513.00M | $429.00M | $323.00M | $344.00M | $486.00M | $390.00M | $407.00M | $476.00M | $579.00M |
| QoQ Change | — | -0.9% | -7.6% | -8.9% | -1.9% | -67.3% | -1.6% | +9.2% | +283.7% | -33.8% | -16.4% | -24.7% | +6.5% | +41.3% | -19.8% | +4.4% | +17.0% | +21.6% |
| YoY Change | — | — | — | — | -18.1% | -70.8% | -68.4% | -64.9% | — | +172.9% | +131.9% | +59.9% | -55.6% | -5.3% | -9.1% | +26.0% | +38.4% | +19.1% |